Sublingual versions require a prescription and guidance on dosage, so be sure to discuss this option with a provider at Pure Med Spa to see if it suits your lifestyle
All three of these medications share a common side effect profile rooted in their GLP-1 activity, but each also has unique characteristics worth understanding
Injectable semaglutide has also been approved to reduce the risk of major cardiovascular events, and to reduce the risk of kidney disease worsening in adults with type 2 diabetes and chronic kidney disease

Well let the digital stacks of research below answer that for you: Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis Once-Weekly Semaglutide in Adults with Overweight or Obesity A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder Weight-Loss Drugs Like Ozempic Are Treating Binge Eating, Too Dulaglutide Reduces Binge Eating in Patients With T2D and Binge Eating Disorder Tirzepatide Once Weekly for the Treatment of Obesity Wegovy (semaglutide): a new weight loss drug for chronic weight management Liraglutide for psychiatric disorders: clinical evidence and challenges The use of GLP-1 agonists in the treatment of binge-eating disorder, emotional eating, overweight, and food noise offers much hope and promise to those who have struggled with these debilitating lifelong issues

Severe Diarrhea Or Ongoing Stomach Side Effects Frequent diarrhea can also affect the absorption of your oral contraceptive
doi:10.1016/j.bbrc.2012.07.086 Tsai CY, et al